Trial of Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia (CX516)
This study has been completed.
Sponsor:
North Suffolk Mental Health Association
Collaborator:
Cortex Pharmaceuticals
Information provided by:
North Suffolk Mental Health Association
ClinicalTrials.gov Identifier:
NCT00235352
First received: October 6, 2005
Last updated: February 25, 2009
Last verified: February 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | February 2007 |
| Primary Completion Date: | April 2005 (Final data collection date for primary outcome measure) |